Literature DB >> 6524980

Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome.

H Yazici, Y Tüzün, H Pazarli, S Yurdakul, Y Ozyazgan, H Ozdoğan, S Serdaroğlu, M Ersanli, B Y Ulkü, A U Müftüoğlu.   

Abstract

Eye disease, arthritis, folliculitis, and thrombophlebitis were more common among males, and erythema nodosum among females, in 297 patients with Behćet syndrome (BS) at their first visit despite an identical disease duration. Younger males and females (age of onset 24 years or less) had a higher prevalence of eye disease and total clinical activity than did the older patients (age of onset 25 years or more). Among the 51 patients followed up for 52 months (SD 7 months) the total clinical activity became significantly less (p less than 0.05) in the whole group at the end of this period. This was particularly true for older females. While male sex and a younger age of onset are associated with more severe disease in BS, overall, the syndrome ran an improving or stable course over 4 1/2 years.

Entities:  

Mesh:

Year:  1984        PMID: 6524980      PMCID: PMC1001536          DOI: 10.1136/ard.43.6.783

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

1.  The arthritis of Behçet's disease: a prospective study.

Authors:  S Yurdakul; H Yazici; Y Tüzün; H Pazarli; B Yalçin; M Altaç; Y Ozyazgan; N Tüzüner; A Müftüoğlu
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

2.  Behçet's disease as seen in Turkey.

Authors:  H Yazici; Y Tüzün; H Pazarli; S Yurdakul; B Yalçin; A Müftüoglu
Journal:  Haematologica       Date:  1980-06       Impact factor: 9.941

3.  The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.

Authors:  H Yazici; Y Tuzun; H Pazarli; B Yalcin; S Yurdakul; A Muftuoglu
Journal:  J Rheumatol       Date:  1980 Mar-Apr       Impact factor: 4.666

4.  Behçet's disease: lack of correlation of clinical manifestations with HLA antigens.

Authors:  A U Müftüoğlu; H Yazici; S Yurdakul; H Pazarli; Y Ozyazgan; Y Tüzün; M Altaç; B Yalçin
Journal:  Tissue Antigens       Date:  1981-02

Review 5.  Behçet disease (Behçet syndrome).

Authors:  T Shimizu; G E Ehrlich; G Inaba; K Hayashi
Journal:  Semin Arthritis Rheum       Date:  1979-05       Impact factor: 5.532

  5 in total
  67 in total

Review 1.  Pulmonary manifestations of Behçet's disease.

Authors:  F Erkan; A Gül; E Tasali
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

Review 2.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

3.  Atypical manifestations in Brazilian patients with neuro-Behçet's disease.

Authors:  Lívia Almeida Dutra; Célio Roberto Gonçalves; Pedro Braga-Neto; José Luiz Pedroso; Alberto Alain Gabbai; Orlando Graziani Povoas Barsottini; Alexandre Wagner Silva de Souza
Journal:  J Neurol       Date:  2011-12-15       Impact factor: 4.849

4.  Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial.

Authors:  Y Ozyazgan; S Yurdakul; H Yazici; B Tüzün; A Işçimen; Y Tüzün; T Aktunç; H Pazarli; V Hamuryudan; A Müftüoğlu
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

5.  Gender influence on ocular manifestations and their outcome in Behcet's Disease. A long-term follow-up of up to 20 years.

Authors:  Fereydoun Davatchi; Farhad Shahram; Hormoz Shams; Abdolhadi Nadji; Cheyda Chams-Davatchi; Massoomeh Akhlaghi; Seyedeh Tahereh Faezi; Farima Ashofteh; Bahar Sadeghi-Abdollahi
Journal:  Clin Rheumatol       Date:  2010-09-22       Impact factor: 2.980

6.  Late-onset Behçet's disease: demographic, clinical, and ocular features.

Authors:  Gulten Sungur; Dicle Hazirolan; Emre Hekimoglu; Remzi Kasim; Sunay Duman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-07       Impact factor: 3.117

Review 7.  Behçet's syndrome.

Authors:  Yusuf Yazici; Sebahattin Yurdakul; Hasan Yazici
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

Review 8.  Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.

Authors:  Gulen Hatemi; Yesim Ozguler; Haner Direskeneli; Alfred Mahr; Ahmet Gul; Virna Levi; Sibel Z Aydin; Gonca Mumcu; Ozlem Sertel-Berk; Randall M Stevens; Hasan Yazici; Peter A Merkel
Journal:  J Rheumatol       Date:  2015-09-15       Impact factor: 4.666

9.  Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease.

Authors:  Leyla Suna Atmaca; F Nilüfer Yalçindağ; Ozden Ozdemir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-17       Impact factor: 3.117

10.  Confusing untypical intestinal Behcet's disease: Skip ulcers with severe lower gastrointestinal hemorrhage.

Authors:  Zhen-Kai Wang; Hui Shi; Shao-Dong Wang; Jiong Liu; Wei-Ming Zhu; Miao-Fang Yang; Chan Liu; Heng Lu; Fang-Yu Wang
Journal:  World J Gastrointest Endosc       Date:  2014-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.